Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia. (2013)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2013-01-477133
PubMed Identifier: 23974202
Publication URI: http://europepmc.org/abstract/MED/23974202
Type: Journal Article/Review
Volume: 122
Parent Publication: Blood
Issue: 15
ISSN: 0006-4971